Position in QNCX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$111,100
-$1,681,900 QoQ
Shares Held
5,500
0.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 46 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $24,764,827 across 166 Biotechnology names. QNCX ranks #21 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
51,990 | $4,893,296 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,953 | $3,054,242 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,218 | $2,330,040 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,314 | $2,089,107 | |
| 5 | RPRX |
Royalty Pharma plc
|
33,855 | $1,624,023 | |
| 6 | EXEL |
Exelixis, Inc.
|
29,442 | $1,262,766 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
138,897 | $1,176,456 | |
| 8 | WVE |
Wave Life Sciences Ltd.
|
144,950 | $1,050,887 |
All Filings in QNCX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $111,100 | 5,500 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $1,793,000 | 5,500 | Shares | Sole | 2025-11-18 | |
| 2023-12-31 | $220,500 | 1,050 | Shares | Sole | 2024-02-09 | |
| 2023-03-31 | $327,600 | 1,050 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $133,770 | 1,050 | Shares | Sole | 2023-02-13 | |
| 2021-06-30 | $1,060,000 | 100 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $277,800 | 50 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $500,000 | 50 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $456,100 | 50 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||